Does Dr. GRACE ASHU-NGANG have financial conflicts of interest?

Dr. GRACE ASHU-NGANG (NURSE PRACTITIONER) has received a total of $1,654 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,654 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. GRACE ASHU-NGANG?

According to CMS Open Payments data, Dr. GRACE ASHU-NGANG received funding from ABBVIE ($553), ALKERMES ($297), and OTSUKA AMERICA PHARMACEUTICAL ($247).

Does Dr. GRACE ASHU-NGANG receive research grants or speaking fees?

Dr. GRACE ASHU-NGANG has received $1,654 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. GRACE ASHU-NGANG

NURSE PRACTITIONERReal-Time Hydrated

Specialty: Nurse Practitioner, Psych/Mental Health

Practice Location: BELTSVILLE, MD 20705

NPI Number: 1477915460

LIFETIME INDUSTRY VALUE

$1,654

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ASHU-NGANG is a verified Nurse Practitioner, Psych/Mental Health practitioner based in BELTSVILLE, MD.

Between 2021 and 2025, Dr. ASHU-NGANG had an overall industry promotional and research financial footprint of $1,654 as recorded in the federal CMS Open Payments database.

$1,654 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ASHU-NGANG's primary funding source is ABBVIE, which accounts for $553 (representing 33.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$553

33.4%

ALKERMES

Rank 2

$297

17.9%

OTSUKA AMERICA PHARMACEUTICAL

Rank 3

$247

14.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.